Tvardi Therapeutics to Host KOL Webinar on the Clinical Potential of TTI-109 in Ulcerative Colitis (UC) and the Evolving Treatment Landscape, on August 19, 2026
Globe Newswire•12/08/2026•08:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.